News Focus
News Focus
Followers 177
Posts 16210
Boards Moderated 1
Alias Born 01/26/2016

Re: FeMike post# 505781

Wednesday, 08/17/2022 10:44:37 AM

Wednesday, August 17, 2022 10:44:37 AM

Post# of 822672
FeMike,

You are correct but.. they would only get the license based on the need to have one for commercial scale production of some product. If that product was for anything other than DCVax-L initially, NWBO/Linda would be in serious trouble since Sawston, unlike Cognate, did not significantly contribute to the trial process to benefit NWBO shareholders and Specials certification is a lesser cert. Sawston must be certified based on DCVax-L commercializtion or the blowback on Linda/Toucan would have teeth. They won’t go there without serious repercussions hence they won’t go there. Therefore, speculation that Sawston would be approved commercially without a focus on L is speculation without any serious merit. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News